𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏 @CParkMD Twitter profile

Pinned Tweet

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

2 months

⭐️What to look 👀 for in your urine for cancer? Honored to film this public announcement for cancer awareness @BladderCancerUS @WorldBladderCan @IBCG_BladderCA @AmericanCancer #PatientCare #Healthcare #CancerAwareness #KnowledgeCanDiminishFear

25

140

351

Last Seen Profiles

@stw_pdg

@XPERION_NXT

@jamesduffy22

@Bokepindoo2023

@bocilwindows

@comfuturesuk

@nexusbot_blaine

@The_Nooran

@solinscription

@antidepresnn

@stw46

@stw_pdg

@nono_puce97

@BlazeAleksander

@ToddGlass

@stw_pdg

@junsui3d

@Nutto1760975117

@stw46

@bazi1val

@bokeplokalmalam

@trucalling9278

@young__boy_

@bokeplokalmalam

@peacefrog_eth

@SecretlyKobe

@cukienaknikmati

@BandarStw

@ch44636686

@IrellandManella

@nbcsnl

@podcastage

@stw46

@bokeplokalmalam

@hijabjilbab1

@stw_pdg

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Great honor to be published in NEJM as PI and Author w/ these outstanding VISION Investigators👇THANK YOU 🙏 to our prostate cancer patients for enrolling in our groundbreaking study. ⭐️BIG THANKS to Dr. Sartor & Dr. Morris for OUTSTANDING LEADERSHIP.

85

567

1K

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️Asteroid Sar2667 just before Earth impact, on Feb 13, 2023. 💫 ☄️ #Sar2667

3

77

202

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Darolutamide/Docetaxel/ADT becomes new STANDARD of CARE for newly diagnosed metastatic prostate cancer patients w/a 32.5% ⬇️ risk of death 🙏As co-Author & co-PI of ARASENS study, THANK YOU to our patients. 👇JUST published in NEJM👇 @OncoAlert

5

59

181

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

🌟Prostate Cancer circulating tumor DNA (ctDNA) 🧬 showing PROMISE. 👉Blood ctDNA helps 👩‍⚕️ 👨‍⚕️ physicians identify p53 & RB1 tumor suppressor gene loss/AR-independent neuroendocrine carcinoma phenotypes to guide correct treatments. Click 👇 @OncoAlert

3

55

152

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Great honor to be published in the NEJM as a Principal Investigator 👇 with these outstanding investigators. I am PROUD our research team at Norton Cancer Institute had the 2nd HIGHEST enrolling number of patients in the United States for the development of Enfortumab Vedotin

11

26

150

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️PRACTICE changing paper in NEJM. Darolutamide, ADT & Docetaxel combo significantly improved OS. 🙏THANK YOU to our Research team & Patients in our trial. 🙏 Great honor to be a PI with this outstanding group of GU oncologists. @OncoAlert 👇

6

50

136

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️ Checkmate 274 trial UPDATE at median follow-up 36.1 months. Median DFS 22.0 months Nivolumab vs 10.9 months w/placebo, [HR] 0.71. ✅Patients w/ PD-L1 ≥1%, Nivolumab median DFS 52.6 mo vs. 8.4 mo w/placebo (HR 0.52) 🤯 @ASCO #GU23 @OncoAlert

3

52

129

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Practice changing NEJM paper. Stage II & Stage III Triple Negative Breast Cancer. 36 month EFS was 84.5% (95% CI [CI], 81.7 to 86.9) pembrolizumab–chemotherapy arm, as compared with 76.8% (95% CI, 72.2 to 80.7) in the placebo–chemotherapy arm. @OncoAlert

2

53

131

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

☑️Outstanding data just published in NEJM. Median event-free survival, 31.6 months w/ nivolumab ➕chemo 20.8 months w/ chemo alone. % patients w/ pathological complete response w/ immuno + chemo 👉24.0% to 2.2% chemo alone @OncoAlert #lcsm #lungcancer 👇

1

42

129

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

🌟Just ANNOUNCED. 1st ever LAG-3 immunotherapy approved by the FDA for 1️⃣st line metastatic melanoma w/Nivolumab. Congratulations to Dr. Tawbi, his co-Principal Investigators, & the melanoma study patients for their contribution to science. @OncoAlert

3

38

120

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️ Great talk by Dr. Hope Rugo. 6️⃣5️⃣% of breast cancer patients with HR+ are HER2-low. 3️⃣7️⃣% of triple negative breast cancer patients are HER2-low. @OncoAlert

2

42

117

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Did you know 43% of patients with NSCLC have mutations that are targetable with APPROVED agents? Masterful discussion by Dr. Melissa Johnson at the Masters Lecture Series with the current targetable medications to best treat our lung cancer patients . @OncoAlert

4

33

115

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️How to TREAT metastatic triple negative breast cancer. Dr. Gregory Vidal, Director of Breast Oncology at West Cancer Center and Regional Health Series provides an easy to follow table to help our breast cancer patients at the Masters Lecture Series. @OncoAlert

3

41

114

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

OUTSTANDING discussion of the current landscape of HER2+ Breast Cancer by leading expert Dr. Hope Rugo at the NOSCM this morning. ❤️ this algorithm for early disease HER2+ Breast Cancer treatments. @OncoAlert

8

36

108

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

✅Do ALL renal cell cancer patients require adjuvant Pembrolizumab after nephrectomy? Dr. Katy Beckermann provides a masterful discussion at our Masters Lecture Series. @OncoAlert

1

25

101

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

6 months

⭐️Best part of ASCO GU are our friends and colleagues. #Highlights #GU24 @DrYukselUrun @shilpaonc @DrChoueiri @montypal @AndreaNecchi @neerajaiims @AmandaNizamMD @AJangMD @FaltasLab @TiansterZhang @crisbergerot @LauraBukavinaMD @BraunMDPhD @yekeduz_emre

9

23

97

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

10 months

⭐️Unprecedented amount of PRACTICE CHANGING studies in GU oncology @myESMO this weekend. Looking forward to seeing these presentations from @BradMcG04 @DrChoueiri @neerajaiims @tompowles1 @apolo_andrea @sartor_oliver @Silke_Gillessen @OncoAlert Dates and times 👇

1

30

96

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️FDA APPROVED. As co-PI of ARASENS, a BIG THANK YOU🙏 to our prostate cancer trial patients & families. 🎉Congrats to my AMAZING team at Norton Cancer Institute for enrolling the HIGHEST number of patients in the country. 👇 @OncoAlert

2

24

95

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️How to TREAT early stage Triple Negative Breast cancer. Dr. Hope Rugo shares her algorithm for medical oncologists to use in their clinical practice right away. @OncoAlert @hoperugo

0

32

94

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 months

🌸 Happy Mother”s Day from our family to yours. Wishing all of the mothers out there a day filled with love, joy, and appreciation. #HappyMothersDay2024 #ILoveMyMother #MyMomsBucketList #HotAirBalloonRide

4

13

90

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

@AaronGoodman33 Great case! As a former radiology resident. Loss of SI joint is what is MOST pathognomonic of Ankylosing Spondylitis

1

9

88

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

✅IMPRESSIVE Adagrasib data for metastatic NSCLC pts w/KRASg12c Mutation. 42.9% pts w/objective response(ORR). Preclinical studies show adagrasib penetrates CNS. Pts w/stable CNS Mets intracranial ORR 33.3%. #lcsm #ASCO22 #JustPublished 👇 @OncoAlert

0

24

79

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

6 months

💡Prostate Cancer Biochemical Recurrence algorithm by Dr. Channing Paller @hopkinskimmel @jacobadashek @ASCO #GU24 @neerajaiims @DrYukselUrun @crisbergerot @urotoday @yekeduz_emre @oncodaily @PCFnews

0

32

78

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

✅JUST RELEASED by @tompowles1 @DrChoueiri et al : Pembrolizumab as post-nephrectomy adjuvant tx for clear cell renal cell carcinoma (30-month follow-up). 👉DFS better w/ Pembro compared to placebo (HR 0·63 [95% CI 0·50–0·80]). @OncoAlert 👇click👇

0

18

76

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Congrats to my former Chair and mentor Dr. Jame Abraham for becoming the new Chairman of @ClevelandClinic Hematology/Oncology. Perfect role model. Patients LOVE him, outstanding leader, wonderful teacher, research expert. Most importantly a KIND and GREAT person. @jamecancerdoc

4

9

76

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

🎉 Congratulations Dr. Yan Leyfman @YLeyfman for being selected a rising star and emerging leader under age 40 for his research in cancer care, COVID 19, and global medical education. We are all very proud of you. @PatrickHwuMD @Dr_R_Kurzrock @drdonsdizon @weldeiry

13

12

74

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

✅Dr. Luis Raez gives us a great overview and and an easy to review table for First Line Therapy with NO actionable mutations. @OncoAlert

0

24

67

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

We are THRILLED to present the VISION study @ASCO 2021. As a PI and Author, we would like to THANK our prostate cancer patients for enrolling in this groundbreaking study. Thank you to leadership of Dr. Michael Morris Dr. Oliver Sartor & VISION authors .

3

16

70

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️ctDNA 🧬 from Non small cell lung csncer patients suggests that the likelihood of disease relapse decreases ⬇️ for high-risk stage II/III patients after 18 months without ctDNA detection. 🎯 Click 👇 @OncoAlert

0

23

66

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

Always GREAT to see Toni. He is always kind and generous to help junior people in the GU field. Thank you @DrChoueiri for connecting me to research leaders in liquid biopsy. @ASCO #GU23

1

3

68

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️My good friend @PGrivasMDPhD and I talk about the importance of Mentorship in Oncology. We discuss people we admire such as Dr. Neeraj Agarwal and Dr. Monty Pal for being outstanding mentors. Also we discuss @DRBakaloudiMD journey to win the @ConquerCancerFd merit award.

4

19

70

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

9 months

⭐️It was fun to catch up with good friends. #ESMO23 @myESMO @BrunoBastosMD @koshkin85 @DrYukselUrun @PGrivasMDPhD

2

6

45

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️Goose Bumps and a Standing Ovation @ASCO is a magical experience. ❤️ talking to Dr. @RamalingamMD about his 1st patient with EGFRm over ten years ago to his plenary session yesterday. 👇Join us tonight on @OncLive #ASCO24 We discussed the LAURA study

0

16

66

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

🎉Happy Birthday Petros 🎂 #GU22 @OncoAlert

1

4

65

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 months

❤️ this #AUA24 walk to support Bladder Cancer Patients. @ParamMariappan @UroDocAsh @shilpaonc @PGrivasMDPhD @IBCG_BladderCA @BladderCancerUS @JanetKukreja @AmandaMyersMD @AndreaNecchi @spsutkaMD @jteoh_hk @JenniferARegala @DrYukselUrun @OncLive

3

18

64

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Gut microbiome 🦠 changes can result in the development of several diseases, including prostate cancer. ➡️Gut-prostate axis is evaluated as a potential target 🎯 for the treatment of prostate cancer. #pcsm Click ⬇️ @OncoAlert

0

25

59

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

10 months

⭐️Practice Changing EMBARK Trial 1️⃣Prostate CA w/biochem recur 👉PSA doubling time less than 9 months 2️⃣ Three arms👉enzalutamide +ADT, enzalutamide, or ADT 3️⃣ 5 year Mets Free Surv 👉87% Enza+ADT, 80% Enza, 71%ADT 👇 HRQoL data at #ESMO23 @OncoAlert

2

26

59

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

THRILLED to announce our LIVE 1 day Masters Oncology meeting with LEADING cancer docs in America with updates from @ASCO 2021 in Nashville, Tennessee. OUTSTANDING Faculty from Sarah Cannon, Vanderbilt, Brown University Cancer Center, Dana Farber, Iowa 👇

3

17

58

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

💡OUTSTANDING #ASCO23 @OncoAlert update on “Effect on outcomes of toxicity-related dose reduction in TKI monotherapy or TKI-IO combination therapy for adv. renal cell carcinoma”, by rising GU superstar Dr. Amanda Nizam @AmandaNizamMD . @weoncologists 👇

1

17

60

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️Always FUN to catch up with these passionate @ASCO leaders that are blazing the trail in medical oncology. ❤️ their infectious enthusiasm to help cancer patients, spearhead ASCO initiatives, and inspire medical oncology trainees. @CathyEngMD @drdonsdizon

1

6

57

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️Great to see Monty at @ASCO #GU23 and congratulate him on his election to @ASCO nominating committee. He is an outstanding mentor for his mentees and he will use the same interpersonal skills to be an outstanding leader for @ASCO .

1

3

56

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Dr. Maryam Lustberg gives a Masters Series Lecture and provides a Treatment Algorithm on how to treat metastatic HER2 Breast Cancer. @OncoAlert

0

10

55

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

✅Authoritative ASH Guidelines to help our cancer patients in the prevention and treatment of DVT and PE👇 👏Outstanding job by Dr. Lyman and his great team @gary_lyman on when to use Oral Anticoagulants 💊, Heparin, and Enoxaparin💉 #cancer #VTE #DVT

1

19

53

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️Can you give PARP inhibitor alone (WITHOUT ADT) for BRCA1, BRCA2, or CHEK2 metastatic hormone sensitive prostate cancer patients? ORR 60% for BRCA2 patients. Small study but very intriguing by #MarkMarkowski and #EmmanuelAntonarkis @ASCO #GU23 #PosterSession @OncoAlert

1

20

53

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

✅As a selection committee member of @OncLive Giants of Cancer Care, I am happy to announce nominations just opened for Class of 2024. 👇Nominate a candidate👇 @PTarantinoMD @PGrivasMDPhD @jacobadashek @OncBrothers @HemOncFellows @HemOncWomenDocs

1

17

52

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️MUST READ Interdisciplinary consensus on how to treat our patients with brain metastases with renal cell carcinoma by @EJonasch @DrDanielHeng @BradMcG04 @brian_rini @DrChoueiri et al Click below👇 @OncoAlert

0

34

52

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

🎉CONGRATULATIONS to my good friend @PGrivasMDPhD for becoming a Full Professor @fredhutch @UWDeptMedicine . VERY FORTUNATE to have worked closely with him on research & education. Petros is a SUPERSTAR scientist, STELLAR clinician, and most importantly a GREAT person. @OncoAlert

3

8

52

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️BEST parts of @ASCO #GU23 1️⃣Catching up with friends 2️⃣Learning new ideas 3️⃣FUN conversations 4️⃣Making new friends. @MehtaScribe @neerajaiims @montypal @cparker399 @AmandaNizamMD @PGrivasMDPhD @DRBakaloudiMD @AJangMD @ZakhariaYousef @rohitjainMD @koshkin85 @Tanjin097

4

9

50

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️As a selection committee member @OncLive Giants of Cancer Care for close to ten years, it is w/great pleasure we celebrate 2024 inductees. Join us as we hear stories of luminaries in oncology and their journey to prominent contributions in oncology. 👇

2

14

51

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

❤️the camaraderie in the GU oncology community with the nicest and most friendly people W/ Dr. Shilpa Gupta, Dr.Neeraj Agarwal, and Dr. Bishop Faltas. #GoodTimes #GoodFriends #ASCO22 #ASCOiSpy @ASCO @OncoAlert

2

4

50

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️Join me and my good friend Dr. Pedro Barata in #Cleveland on Saturday August 19. We will have Global leaders in GU oncology on “How the Masters treat Kidney, Bladder, and Prostate cancers” @PBarataMD @DrChoueiri @shilpaonc @GUONCGarciaJA 👇Click here 👇

1

14

50

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️Some renal cell cancer patients that receive adjuvant Pembro based on KEYNOTE-564 may ALREADY be CURED but are OVER treated w/risk of developing toxicity. Is there a role for MRD to find these patients? Dr. Arnab Basu answers this❓at @ASCO #GU23 👇

3

18

50

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️We are honored to have Dr. Navneet Majhail, Deputy Physician-in-Chief of Blood Cancers @SarahCannonDocs and President of @ASTCT ‘19-20 give a Keynote on CAR-T cell and cellular therapies at our How the Masters Treat meeting. 👇Join us tomorrow 👇

3

5

50

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️Ok…one of us ( @BGarmezy @montypal @alantanmd ) has to to sing karaoke tonight @Uromigos since the CheckPoints are fully booked. Who wants to sing an @oasis song? Any volunteers? @brian_rini @tompowles1 @shilpaonc @PGrivasMDPhD @neerajaiims @DrKarineTawagi @JasonBrownMDPhD

3

7

49

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

Dear Pathologists, We were in a room the size of an aircraft hangar w/thousands of oncologists doing a standing ovation. Now at EVERY breast tumor board you will have FIERCE debates on HER2 IHC 1+ vs IHC 0+. Progress is coming. Good luck, Chandler, Yan, and Mark #ASCO22

3

12

48

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Outstanding discussion of data in metastatic hormone sensitive prostate cancer since 2014. Click below to watch LIVE now 👇 #UromigosLive @OncoAlert

0

17

48

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

🌟LOVED discussing TOUGH Prostate and Kidney Cancer Cases w/ @PBarataMD at the New Orleans Summer Conference. 🙏Thank you @EdgardoSantosMD , @SanjivAgarwala , @medical_cons , and @CancerExpertNow for inviting us to share real life scenarios that are NOT in the @NCCN guidelines.

3

11

45

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️What an OUTSTANDING GU oncology roundtable. We discussed non clear cell RCC, 1st line metastatic urothelial cancer, and role of PARP inhibitors for mCRPC. Thank you Jorge, Toni, Shilpa, Pedro, and Albert for a great session.

1

7

47

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️Always great to talk to @GlopesMd at the @ASCOPres dinner. ❤️ his energy and passion for @ASCO initiatives including optimizing global cancer care. #ASCO24 @AmanChauhanMD @Latinamd @oncodaily @SylvesterCancer @DrSDNimer @GinaDAmatoMD1 @JTrentMDPhD @BRoseMDMPH @HemOncMiami

1

14

46

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️Great honor to co-host a GU medical meeting for oncologists with Dr. David Aggen from @MSKCancerCenter . Really enjoyed working together as a team and getting to know each other. We are both alums from @UofIllinois . Looking forward to collaborating on future projects

4

3

45

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️How to treat metastatic Urothelial Cancers in 2022. Leading genitourinary oncologist Dr @PGrivasMDPhD gives us an algorithm for medical oncologists to follow in their medical practice next week. @OncoAlert

0

22

45

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️ Just RELEASED NEJM: Ph 3 trial Rucaparib mCRPC patients w/BRCA1, BRCA2, ATM after 2nd gen ARPI. ✅62 mo rPFS 11.2 mo vs 6.4 mo(Ruc vs control) HR 0.50; ITT group(10.2 mo vs 6.4 mo, HR, 0.61) ✅ATM rPFS (8.1 Mo vs 6.8 mo) 👇 @OncoAlert @ASCO #GU23

2

22

45

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Very FIRST CT was performed 50 years in 1971 and it picked up a brain mass. Great article today in the NEJM The CT Scan after 50 years — Continuity and Change | NEJM

0

13

43

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

⭐️OUTSTANDING Update by my friend @DrChoueiri at the International Congress on Immunotherapy today. Highlights include👇 1⃣His 1st line flow chart for metastatic renal cell 2⃣KM curve w/IPI and Nivo for Sarcomatoid mRCC. #StandardOfCare #GoToICIC #Immunotherapy @OncoAlert

0

20

44

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️BIONIKK trial: 1️⃣st prospective biomarker-driven randomized trial in metastatic clear cell renal cell carcinoma. Trial uses a transcriptomic biomarker that reflects intrinsic disease biology to optimize treatment. #JustPublished @OncoAlert 👇

0

14

44

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️Mentor and Mentee Moment at #ASCO24 . Loved learning from Dr. Jame Abraham as his heme onc fellow. Now as a mentor I get to help one of the brightest young minds. #Mentorship #PayItForward @jamecancerdoc @YLeyfman @PGrivasMDPhD @shilpaonc @montypal @neerajaiims

2

7

44

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️How do the LEADING GU oncologists treat Bladder and Renal Cell Cancers in 2022? Join us this Saturday virtually Register for FREE 👇 Dr. Petros Grivas and Dr. Tian Zhang provide EXPERT advice w/Q&A on the Masters Lecture Series. #Gu22

3

9

44

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Great article by Dr. Martinez Reyes on what to expect with new drug targets in the future. Cancer metabolism: looking forward | Nature Reviews Cancer #PrecisionMedicine #NextGenerationSequencing ⁦ @inma_mreyes ⁩ ⁦ @OncoAlert ⁩ ⁦ @DrChoueiri ⁩

2

14

44

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️ How to sequence 1st line Stage IV ER+ positive breast cancer for patients after Destiny-Breast06 at #ASCO24 . Great to talk to global leader Dr. Giuseppe Curigliano and get his expertise on @oncodaily 👇Full video 👇

0

14

44

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️What a FUN night at our 1st @OncLive event in Louisville. Thank you @SharynMFoster @brian_rini @PGrivasMDPhD @LaurenMachos for great night of camaraderie and laughter. @OmniLouisville

3

6

42

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

🙏 Petros and I would like to THANK our friends and colleagues for making Seattle Master’s Lecture Series such a HUGE success. (📸 credit: @DRBakaloudiMD ) . GREAT weekend of camaraderie, laughter and FUN. @PGrivasMDPhD @PavlosMsaouel @naborala @HatimHusainMD @OncoAlert

4

10

43

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

❤️ Dr. Giuseppe Curigliano’s story as a child raised in Toronto to becoming ESMO President. Our @myESMO community is very fortunate to have an outstanding compassionate leader @curijoey 👇Full Video👇 … @ChristianRolfo @PTarantinoMD @PGrivasMDPhD

2

16

43

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️Thank you Jorge for a FUN and magical evening filled with lots of laughter and great camaraderie. #AboutLastNight @GUONCGarciaJA @PBarataMD @shilpaonc @EdgardoSantosMD @DrChoueiri

2

4

42

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️Sacituzumab Govitecan + Pembro for patients with metastatic urothelial cancer post platinum tx. Outstanding presentation by @PGrivasMDPhD and co-investigators @ASCO #GU23 ✅ORR of 41% ✅CBR of 46% ✅DOR 11.1 mo ✅PFS 5.3 mo @OncoAlert 👇

0

13

41

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

⭐️OUTSTANDING Non-Clear Cell Renal Cell Carcinoma Update by Dr. Monty Pal. AMAZING waterfall plot with Checkpoint Inhibitor and Cabozantinib in patients w/metastatic non clear cell renal cell.

0

12

41

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️How do the LEADING Thoracic Oncologists treat #LungCancer in 2022? Dr.Jack West and Dr. Sandip Patel discuss the latest updates with a Q&A at our Masters Lecture Series Join me & @PGrivasMDPhD this Saturday virtually. Register for FREE 👇

1

14

41

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

✈️ Great to be at #ASCO24 . Looking forward to catching up with friends and colleagues. #Chicago #FunWeekend @jacobadashek @YLeyfman @alantanmd @MedNewsWeek @OncLive @oncodaily @ZakhariaYousef @PGrivasMDPhD @shilpaonc @PTarantinoMD @BGarmezy @DrYukselUrun @ASCO

1

8

40

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

✅Dr. Tanios Bekaii-Saab gives us an update on the promising role of Adagrasib in a recent NEJM and @ASCO Plenary session from last month at Masters Lecture Series in Seattle. Strong data👇 @OncoAlert

1

10

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⚡️Fascinating study. Patients that progress on Enzalutamide have very high levels of BCL-2. In this study patients that progress on Enzalutamide have Venetoclax added (a very potent BCl-2 inhibitor for 1st line treatment for CLL and AML). @asco #GU23 #PCa #PosterSession

2

14

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Outstanding Trophy U-01 Oral Presentation by @PGrivasMDPhD Combo of Sacituzumab Govitecan and Pembrolizumab demonstrated an OUTSTANDING 34% ORR with manageable toxicities. Great honor to be a part of this GU research study. Abstract👇 @OncoAlert

0

10

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

We are THRILLED to have Dr. Guru Sonpavde, Director of the Bladder Cancer Program at Dana Farber Cancer Institute and Faculty at @harvardmed School give us a 2021 @ASCO Bladder and Prostate Cancer LIVE update tomorrow. Join us in person in Nashville 👇

0

4

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

⭐️JUST published in NEJM. NEW standard of Care for 2nd line relap/refrac large B-cell lymphoma patients . Axicabtagene ciloleucel led to 60% improvement in event-free survival vs Standard of Care 2nd-line chemo tx. Phase 3 ZUMA-7 trial @OncoAlert #ASH21

1

10

38

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Implications of KEAP1 and TP53 (Co)mutation in Lung Adenocarcinoma: Another Bullet for Immunotherapy? - Journal of Thoracic Oncology #LungCancer @OncoAlert

0

14

38

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

⭐️Always LOVE seeing my former chairman Dr. Jame Abraham. It is a GREAT honor to be one of his former Heme/Onc fellows. #ASCO23 @jamecancerdoc @shilpaonc @n8pennell @AmandaNizamMD @PGrivasMDPhD @BldCancerDoc @OncoAlert

1

3

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️FUN @Uromigos LIVE event.Thank you @brian_rini @tompowles1 for a STELLAR event w/GU ALL-STARS and the invitation to join you guys in beautiful Nashville. 👇Bladder 👇Prostate 👇Renal Cell @OncoAlert

0

18

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

3 years

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity | Nature Cancer #gicsm #immunotherapy #oncology #liversurgery

Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into...

Nature Cancer - Yarchoan and colleagues present a single-arm phase 1 clinical trial of cabozantinib with immune checkpoint inhibition for patients with hepatocellular carcinoma. Using...

www.nature.com

1

17

37

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

5 months

🎯Practice changing👉EV-302 just published in NEJM for 1st line metastatic urothelial cancer👇 1️⃣ OS 👉 Enfortumab vedotin-Pembro 31.5 months vs. 16.1 months chemo 2️⃣ PFS 👉12.5 months EV-P vs. 6.3 months chemo. 3️⃣ ORR 👉EV-P 67.7% vs. chemo 44.4%

0

18

39

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

✅ Dr. Petros Grivas and I are THRILLED to have our Master’s Lecture Series in Seattle with an All Star Line Up of leading oncology experts in the country. Join us as we discuss latest 2023 data. @OncoAlert @PGrivasMDPhD @GIcancerDoc @neerajaiims @jrgralow @naborala @hoperugo

2

8

36

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

❤️ the beautiful Chicago Skyline. Great to be here for @ASCO #ASCO22 #ChicagoNight

1

6

37

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️Congratulations to @montypal for being newly elected as @ASCO Nominating Committee member. We are in great hands with his leadership. @OncoAlert

1

3

36

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

✅Insightful discussion by Dr. @PBarataMD on updated Tivozanib clinical studies at @DAVAOnc in Banff. Loved the helpful table that compared TKI toxicities of drugs given for RCC. @OncoAlert

1

12

36

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

✅Thank you Dr. Winer for your 1 year of dedicated service as our outstanding ASCO President. Great honor to introduce my mentee @ShubhAgrawalMD to Dr. Eric Winer at our @ASCO reception on his last day as President. #ASCO23 @OncoAlert

0

7

36

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

⭐️Congratulations to Dr. John Marshall for his 2024 Giants of Cancer Care induction. LOVED our #ASCO24 conversation on KRASG12C and when yo you use T-DXD for Stage IV colorectal cancer patients based on the April 2024 @US_FDA pan tumor approval for HER2 IHC 3+ @marshalj23 We

0

10

35

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 months

🫁 Lung cancer studies were the most impactful at #ASCO24 . However GU oncologists still had some influence. @ASCO @OncLive @YLeyfman @MedNewsWeek

2

11

35

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

6 months

⭐️Outstanding UNITE study discussion by @AmandaNizamMD . Study discussed EV after platinum chemo and switch maint avelumab in Urothelial Cancer 👉ORR 51% 👉PFS 7.0 mod 👉OS 13.3 mos @PGrivasMDPhD @koshkin85 @shilpaonc @rafee_talukder @jamecancerdoc

1

14

35

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

1 year

💡Every July, new doctors start in America. As a physician, we must ALWAYS remember, It is an HONOR and PRIVILEGE to help patients. #TipsForNewDocs #Trust #Relationships #PatientCare #LifelongLearning #MedTwitter @weoncologists @HemOncFellows

2

7

35

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

5 months

🎉Congratulations Dr. Yan Leyfman for your OUTSTANDING oral presentation at the 2024 Tandem Meeting. We are PROUD of your great research presentation and relentless work ethic. @YLeyfman #Tandem24 👇 @cardismith @AMalone2012 @christinemphmd

3

11

35

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️OUTSTANDING @ASCO Direct Miami meeting hosted by Symposium Director @LuisERaez1 and @MCIStrong Education Committee. Over 350+ medical professionals in the audience. It was an honor to join the 50+ expert faculty to discuss ASCO 2022 highlights this weekend. @OncoAlert

1

13

32

𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

@CParkMD

2 years

⭐️ Outstanding teaching case by Dr. Barata on how to treat oligometastatic renal cell cancer patients with sarcomatoid features in the checkpoint era at the New Orleans Summer Conference. @OncoAlert

1

7

33